Skip to content

Effects of immersive virtual reality for preventing and managing anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy: An exploratory trial

Effects of immersive virtual reality for preventing and managing anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy: An exploratory trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021694
Enrollment
Unknown
Registered
2019-03-05
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients receiving first chemotherapy

Interventions

Experimental group:Immersive virtual reality intervention
Control group:Standard care

Sponsors

The Nethersole School of Nursing, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients who are (1) aged between 6 and 12 years; (2) chemotherapy naive; (3) scheduled to receive their first intravenous chemotherapy; (4) can understand Chinese.

Exclusion criteria

Exclusion criteria: Patients who have (1) identified cognitive and learning problems in their medical record; (2) brain tumours or metastasis; (3) identified contact precautions; (4) previous history of seizures or motion sickness.

Design outcomes

Primary

MeasureTime frame
Anxiety;Heart rate and mean arterial blood pressure;Anticipatory nausea and vomiting;Acute nausea and vomiting;

Secondary

MeasureTime frame
parent and nurse satisfaction levels toward the chemotherapy procedure;Satisfaction to the immersive virtual reality intervention;Feasibility of intervention;

Countries

China

Contacts

Public ContactCho Lee Wong

The Chinese University of Hong Kong

jojowong@cuhk.edu.hk+852 39438166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026